HLA-E and cancer: ITF3756 also affect the gene expression level of HLA-E (the non-classical human leukocyte antigen-E), an antigen constitutively expressed on nucleated cells at low levels but reported to be overexpressed in multiple solid tumors and associated with worse clinical outcome in different cancers (57).